A new class of peptide-based nootropics is emerging from Russian and American research institutions. Semax, Selank, and Dihexa represent fundamentally different approaches to cognitive enhancement — from ACTH analogs to BDNF mimetics — each with distinct mechanisms and evidence profiles.
Semax: The ACTH Analog
Semax is a synthetic analog of ACTH(4-7) developed at the Institute of Molecular Genetics in Moscow. It upregulates BDNF and NGF, enhances dopaminergic and serotonergic neurotransmission, and has demonstrated neuroprotective effects in stroke models. It is approved in Russia for stroke recovery and cognitive decline.
Selank: Anxiolytic and Cognitive
Selank is a synthetic analog of the immunomodulatory peptide tuftsin. It modulates GABA-A receptor function (similar to benzodiazepines but without dependence potential), increases BDNF expression, and regulates cytokines. Research subjects report reduced anxiety with concurrent improvements in memory and focus.
Dihexa: The BDNF Amplifier
Dihexa (PNB-0408) is a hexapeptide derived from angiotensin IV, developed at Washington State University. It is approximately 10 million times more potent than BDNF at inducing synaptogenesis. Animal studies show dramatic improvements in cognitive performance in Alzheimer models.
Combination Protocols
Semax and Selank are frequently combined in research protocols — their complementary mechanisms create a balanced cognitive enhancement profile. Dihexa is typically used alone due to its potency and longer duration of action. N-Acetyl Semax Amidate is increasingly preferred over standard Semax for enhanced blood-brain barrier penetration.
Administration Routes
Cognitive peptides are commonly administered intranasally, which provides direct access to the brain via the olfactory nerve pathway, bypassing the blood-brain barrier. Intranasal administration achieves higher CNS concentrations with lower systemic doses compared to subcutaneous injection.
FDA Disclaimer
The statements made within this website have not been evaluated by the US Food and Drug Administration. The information provided is not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many peptides described on this site are not approved by the FDA for human therapeutic use and are classified as research chemicals. Nothing on this site constitutes medical advice.
